CompletedNot Applicable

Next Generation CT System

United States64 participantsStarted 2025-04-08

Plain-language summary

The purpose of the study is to collect data to evaluate utility of a next generation CT system in a clinical setting.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Who are 18 year of age or older;
✓. Able to sign and date the informed consent form; AND
✓. Who have in the past 120 days or will in the future 30 days from the day of consent undergo a clinically indicated imaging exam (MRI, CT, radiograph, nuclear medicine, ultrasound, bone material density, interventional radiology procedure) of the head, neck, heart, chest, abdomen, pelvis, or extremities where images are available for this prior exam.

✕. Who are pregnant or lactating;
✕. Who were previously enrolled in this study;
✕. For contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents;
✕. For contrast-enhanced CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel;
✕. Who are in need of urgent or emergent care;
✕. Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; and,
✕. Who are unwilling to have GEHC personnel present for the CT exam.

Data Collection

Timeframe: 12 months

NCT IDNCT06769594

SponsorGE Healthcare

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-03-06